Asia accounted for more than 50% of the global incidence of brain and CSN tumor in 2020, with Mainland China, India, and Japan contributing to majority of the cases.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more